Physician-led medical weight loss with tirzepatide, a once-weekly medication in the GLP-1 category, personalized to your goals and monitored with ongoing support at Kloud
Book AppointmentTirzepatide is a once-weekly prescription injection used in physician-guided medical weight loss. It helps regulate appetite, reduce hunger, and support long-term weight management.
At Kloud, we focus on more than just getting you started on medication. We focus on candidacy, education, thoughtful dosing, side effect support, and a plan that feels sustainable.
You may be a candidate for tirzepatide if:
Tirzepatide is indicated for adults with obesity, or adults with overweight in the presence of at least one weight-related comorbid condition. Final eligibility should be determined during a medical consultation.
Tirzepatide works on pathways involved in appetite and metabolic regulation. Many patients notice:
Official prescribing information describes tirzepatide as a GIP receptor and GLP-1 receptor agonist. The medication is started at a lower dose and increased gradually when appropriate
Physician-led care
Your treatment is guided by a medical team that prioritizes safety, education, and appropriate candidacy.
Personalized dosing
Not every patient needs the same pace. We tailor treatment based on your goals, tolerance, and response over time.
Ongoing support
Weight loss treatment is not one-size-fits-all. We monitor progress, adjust when appropriate, and help you navigate side effects and next steps.
Elevated experience
Kloud combines medical oversight with a calm, design-forward, intentional patient experience in Los Angeles.
Tirzepatide is a prescription medication used for chronic weight management in eligible adults as part of a broader treatment plan.
Tirzepatide acts on both GIP and GLP-1 receptors. Patients often group it into the GLP-1 weight loss category, but it is more specifically a dual GIP and GLP-1 receptor agonist.
Tirzepatide is taken as a once-weekly injection and is typically started at a lower dose before increasing gradually when appropriate.
Adults with obesity, or adults with overweight plus at least one weight-related medical condition, may qualify depending on their evaluation.
Common side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite.
Yes. Treatment should begin with a medical evaluation to determine whether tirzepatide is appropriate and safe for you.
Kloud offers tirzepatide-based medical weight loss treatment. Call or email us for updates on new treatment options.